Through our culture of collaboration, connectivity and data-based science, MD Anderson experts have set the standard for how immunotherapy is used to treat patients with cancer across the globe. Our faculty are working to bring the benefits of immunotherapy to even more patients by integrating immunobiology across all cancer disciplines. MD Anderson’s unique environment and vast resources allow researchers to accelerate novel discoveries into practice-changing therapies that propel us closer to our goal: a world free of cancer.
At the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting, our experts are showcasing pacesetting research and joining colleagues for discussion on the latest science, development and application of immunotherapy.
Below are highlights from our presentations, details about onsite networking opportunities with our experts, and information on our open positions for faculty and trainees.
Featured News
Meet the Experts
Visit MD Anderson at Booth 1027 to network with us, ask a question, learn about training and career opportunities and continue the conversation on key presentations with our experts. Check back for the updated Meet the Experts schedule soon.
Exhibit Hall Hours
Friday, Nov. 8: 9 a.m.–7 p.m.
Saturday, Nov. 9: 9 a.m.–8:30 p.m.
Barista-crafted coffee available at the booth during all hours of the exhibit hall.
Friday, November 8
10–10:30 a.m.
Phase I Clinical Trials: The Foundation of Cancer Drugs
Stéphane Champiat, M.D., Ph.D.
Associate Professor, Investigational Cancer Therapeutics
Jennifer Litton, M.D.
Vice President, Clinical Research
Professor, Breast Medical Oncology
Aung Naing, M.D.
Professor, Investigational Cancer Therapeutics
10:30–11 a.m.
CAR T Cells and T Cell Bispecifics for Hematologic Malignancies
Samer Srour, M.B.Ch.B.
Assistant Professor, Stem Cell Transplantation
11–11:30 a.m.
Immunotherapy for Prostate Cancer: What's New?
Bilal Siddiqui, M.D.
Assistant Professor, Genitourinary Medical Oncology
Sumit Subudhi, M.D., Ph.D.
Associate Professor, Genitourinary Medical Oncology
11:30 a.m.–12 p.m.
Learning from Our Patients: Translational Molecular Pathology
Cara Haymaker, Ph.D.
Associate Professor, Translational Molecular Pathology
Humam Kadara, Ph.D.
Professor, Translational Molecular Pathology
2–2:30 p.m.
Managing Immune Checkpoint Inhibitor Side Effects
Yinghong "Mimi" Wang, M.D., Ph.D.
Professor, Gastroenterology, Hepatology and Nutrition
5:30–6 p.m.
Institute for Cell Therapy Discovery & Innovation
Katy Rezvani, M.D., Ph.D.
Professor, Stem Cell Transplantation
Saturday, November 9
Our research by the numbers
$1.2B
invested in research
1,568
clinical trials
90
patents awarded
From Sept. 1, 2022 to Aug. 31, 2023
Breakthroughs in cancer treatment
Education and Training at MD Anderson
MD Anderson academic programs are competitive and comprehensive. We offer educational opportunities from undergraduate degrees to graduate medical education opportunities.
Why Houston?
As America's fourth-largest city, Houston has a lot to offer. Find out why Houston is a hub for scientific and medical excellence.
